- Report
- March 2024
- 192 Pages
Global
From €3237EUR$3,374USD£2,799GBP
€3597EUR$3,749USD£3,111GBP
- Report
- May 2024
- 186 Pages
Global
From €3237EUR$3,374USD£2,799GBP
€3597EUR$3,749USD£3,111GBP
- Report
- March 2024
- 190 Pages
Global
From €3237EUR$3,374USD£2,799GBP
€3597EUR$3,749USD£3,111GBP
- Report
- January 2024
- 200 Pages
Global
From €2389EUR$2,490USD£2,066GBP
- Report
- April 2024
- 175 Pages
Global
From €4797EUR$5,000USD£4,148GBP
- Report
- February 2024
- 175 Pages
Global
From €4797EUR$5,000USD£4,148GBP
- Report
- February 2024
- 175 Pages
Global
From €4797EUR$5,000USD£4,148GBP
- Report
- January 2024
- 175 Pages
Global
From €4797EUR$5,000USD£4,148GBP
- Report
- May 2024
- 193 Pages
Global
From €4749EUR$4,950USD£4,107GBP
- Report
- October 2023
- 142 Pages
Global
From €2398EUR$2,499USD£2,073GBP
- Report
- June 2023
- 200 Pages
Global
From €7196EUR$7,500USD£6,223GBP
- Report
- October 2023
- 190 Pages
Global
From €4701EUR$4,900USD£4,065GBP
- Report
- October 2023
- 172 Pages
Global
From €4701EUR$4,900USD£4,065GBP
- Report
- February 2024
- 112 Pages
Global
From €4558EUR$4,750USD£3,941GBP
- Report
- February 2024
- 110 Pages
Global
From €4558EUR$4,750USD£3,941GBP
- Clinical Trials
- April 2024
- 50 Pages
Global
From €1439EUR$1,500USD£1,245GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1439EUR$1,500USD£1,245GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1439EUR$1,500USD£1,245GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1439EUR$1,500USD£1,245GBP
- Clinical Trials
- April 2024
- 40 Pages
Global
From €1199EUR$1,250USD£1,037GBP
Amphotericin B is an antifungal drug used to treat a variety of fungal infections, including those caused by Candida, Aspergillus, and Cryptococcus species. It is commonly used to treat systemic fungal infections, such as those affecting the lungs, heart, and central nervous system. It is also used to treat fungal infections of the skin, nails, and eyes. Amphotericin B is a polyene macrolide antibiotic, and is the most commonly used antifungal drug in the world. It is available in both intravenous and oral formulations, and is often used in combination with other antifungal drugs.
The Amphotericin B market is a subset of the larger Infectious Diseases Drugs market. It is a highly competitive market, with a number of companies offering Amphotericin B products. Some of the major players in the market include Pfizer, Merck, Novartis, Sanofi, and AstraZeneca. Show Less Read more